Positron Corp (POSC) stock
POSCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.70+0.15 (+9.68%)
Close on Oct 19, 2026Market cap $55.97MP/E –Yield –
Positron EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Positron's EPS for the twelve months ending Sep 30, 2026 was -$0.32. For fiscal 2025 it was -$0.34. The highest annual figure on record is $0.00 in fiscal 2013.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.34 | – |
| FY2024 | Dec 31, 2024 | -$0.09 | – |
| FY2014 | Dec 31, 2014 | $0.00 | – |
| FY2013 | Dec 31, 2013 | $0.00 | – |
| FY2012 | Dec 31, 2012 | -$4000.41 | – |
| FY2011 | Dec 31, 2011 | -$4000.41 | – |
| FY2010 | Dec 31, 2010 | -$8000.82 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.03 | – |
| Q2 FY2026 | Jun 30, 2026 | -$0.03 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.04 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.22 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.03 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.04 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.05 | – |
| Q3 FY2015 | Sep 30, 2015 | -$0.02 | – |
| Q2 FY2015 | Jun 30, 2015 | -$0.03 | – |
| Q1 FY2015 | Mar 31, 2015 | -$0.04 | – |
| Q4 FY2014 | Dec 31, 2014 | $0.00 | – |
| Q3 FY2014 | Sep 30, 2014 | -$0.13 | – |
| Q2 FY2014 | Jun 30, 2014 | -$0.02 | – |
| Q1 FY2014 | Mar 31, 2014 | -$0.24 | – |
| Q4 FY2013 | Dec 31, 2013 | $0.00 | – |
| Q3 FY2013 | Sep 30, 2013 | $0.00 | – |
| Q2 FY2013 | Jun 30, 2013 | $0.00 | – |
| Q1 FY2013 | Mar 31, 2013 | $0.00 | – |
| Q4 FY2012 | Dec 31, 2012 | $0.00 | – |
| Q3 FY2012 | Sep 30, 2012 | $0.00 | – |
| Q2 FY2012 | Jun 30, 2012 | $0.00 | – |
| Q1 FY2012 | Mar 31, 2012 | $0.00 | – |
| Q4 FY2011 | Dec 31, 2011 | $0.00 | – |
| Q3 FY2011 | Sep 30, 2011 | $0.00 | – |
| Q2 FY2011 | Jun 30, 2011 | $0.00 | – |
| Q1 FY2011 | Mar 31, 2011 | $0.00 | – |
| Q3 FY2010 | Sep 30, 2010 | $0.00 | – |
| Q2 FY2010 | Jun 30, 2010 | -$4000.41 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?